David Atkins joins the National Genomics Board as BIA SME representative
David Atkins, CEO of NGS data analysis software company Congenica, has joined the National Genomics Board to advise on the UK national genomics strategy.
Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
Congenica and Gabriel will develop a highly automated somatic cancer clinical interpretation software platform.
Congenica Contributes to Key Priority within UK Rare Disease Framework
The UK’s Department of Health has published its UK Rare Disease Framework, setting out the key priorities for the rare disease community.
Congenica Launches Patient Advocacy and Engagement Advisory Board
Congenica, today announces the launch of a Patient Advocacy and Engagement Advisory Board.
Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announced it has launched a local cloud solution that will enable ...
2020 – The Year of Healthcare Heroes and International Teamwork
Nick Lench, PhD, Chief Scientific Officer at Congenica describes a year of heartbreak and uncertainty. But it’s also been a year of heroism, where healthcare workers have fought valiantly to save the ...
Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification
As more cases undergo genomic testing and the global supply of classified genomic data increases, reducing repetitive work is essential to scaling access to genomic analysis.
Inclusion in AJHG “Year in Review” 2020
The American Journal of Human Genetics has published its Genomic Medicine Year in Review for 2020, which includes a study featuring Congenica.
Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Dr. Muthu Meyyappan appointed Chief Commercial Officer (CCO), of Congenica. Based in Boston, MA, Muthu will lead Congenica’s global market expansion.
Congenica Appoints Dr. Sam Roberts as Non-Executive Director
Congenica appoints Dr. Sam Roberts as Non-Executive Director to the Board. Sam is the Managing Director of Health & Care at Legal & General.
Inherited Disorders: Bioinformatic Analysis that Surpasses All Others
A recent study has shown that the Congenica platform demonstrated a superior role identifying the genetic causes of platelet-related bleeding disorders
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations